Heart valve fix without the hospital stay? trial tests Same-Day discharge

NCT ID NCT07738575

Not yet recruiting Disease control Sponsor: Hospital Clinic of Barcelona Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial asks whether people with severe aortic stenosis can safely go home the same day after a minimally invasive heart valve replacement (TAVI) instead of staying in the hospital. About 764 patients who are stable six hours after the procedure will be randomly assigned to either same-day discharge or standard care. The study will compare safety outcomes like death, bleeding, stroke, and readmission within 30 days, as well as quality of life and costs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Same-day discharge strategy versus standard hospital discharge after transfemoral TAVI with self-expanding valves
What this could lead to: If same-day discharge proves safe, it could shorten hospital stays and speed recovery for many TAVI patients, reducing healthcare costs.
What could go wrong: The trial is randomized but not blinded, and same-day discharge may carry risks like delayed complications. Results depend on careful patient selection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC STENOSIS AORTIC STENOSIS, SEVERE

Contacts and locations

Locations

Hospital Clínic de Barcelona

Barcelona, Spain
Hospital Universitario 12 de Octubre

Madrid, Spain
Institut Universitaire de cardiologie et de pneumologie de Quebec

Québec, Quebec, G1Y 3K4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.